NCT07148037View on ClinicalTrials.gov

Effect of SLC01B1 (rs4149956) Polymorphism on the Efficacy and Tolerability of Atorvastatin in Pakistani Population

CompletedOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions

Hyperlipidemias

Interventions

GENETIC

Atorvastatin

10mg once a day for 2 months

Trial Locations (1)

Unknown

Riphah International University, Rawalpindi

All Listed Sponsors

lead

Riphah International University

OTHER